Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 61

1.

Bridging islands of information to establish an integrated knowledge base of drugs and health outcomes of interest.

Boyce RD, Ryan PB, Norén GN, Schuemie MJ, Reich C, Duke J, Tatonetti NP, Trifirò G, Harpaz R, Overhage JM, Hartzema AG, Khayter M, Voss EA, Lambert CG, Huser V, Dumontier M.

Drug Saf. 2014 Aug;37(8):557-67. doi: 10.1007/s40264-014-0189-0.

PMID:
24985530
[PubMed - in process]
Free PMC Article
2.

Risk of Upper Gastrointestinal Bleeding From Different Drug Combinations.

Masclee GM, Valkhoff VE, Coloma PM, de Ridder M, Romio S, Schuemie MJ, Herings R, Gini R, Mazzaglia G, Picelli G, Scotti L, Pedersen L, Kuipers EJ, van der Lei J, Sturkenboom MC.

Gastroenterology. 2014 Jun 14. pii: S0016-5085(14)00768-9. doi: 10.1053/j.gastro.2014.06.007. [Epub ahead of print]

PMID:
24937265
[PubMed - as supplied by publisher]
3.

Can Italian healthcare administrative databases be used to compare regions with respect to compliance with standards of care for chronic diseases?

Gini R, Schuemie MJ, Francesconi P, Lapi F, Cricelli I, Pasqua A, Gallina P, Donato D, Brugaletta S, Donatini A, Marini A, Cricelli C, Damiani G, Bellentani M, van der Lei J, Sturkenboom MC, Klazinga NS.

PLoS One. 2014 May 9;9(5):e95419. doi: 10.1371/journal.pone.0095419. eCollection 2014.

PMID:
24816637
[PubMed - in process]
Free PMC Article
4.

Detecting adverse drug reactions following long-term exposure in longitudinal observational data: The exposure-adjusted self-controlled case series.

Schuemie MJ, Trifirò G, Coloma PM, Ryan PB, Madigan D.

Stat Methods Med Res. 2014 Mar 31. [Epub ahead of print]

PMID:
24685766
[PubMed - as supplied by publisher]
5.

Medication-wide association studies.

Ryan PB, Madigan D, Stang PE, Schuemie MJ, Hripcsak G.

CPT Pharmacometrics Syst Pharmacol. 2013 Sep 18;2:e76. doi: 10.1038/psp.2013.52.

PMID:
24448022
[PubMed]
Free PMC Article
6.

Signal detection of potentially drug-induced acute liver injury in children using a multi-country healthcare database network.

Ferrajolo C, Coloma PM, Verhamme KM, Schuemie MJ, de Bie S, Gini R, Herings R, Mazzaglia G, Picelli G, Giaquinto C, Scotti L, Avillach P, Pedersen L, Rossi F, Capuano A, van der Lei J, Trifiró G, Sturkenboom MC; EU-ADR consortium.

Drug Saf. 2014 Feb;37(2):99-108. doi: 10.1007/s40264-013-0132-9.

PMID:
24446276
[PubMed - indexed for MEDLINE]
7.

Discussion of "Biomedical informatics: we are what we publish".

Geissbuhler A, Hammond WE, Hasman A, Hussein R, Koppel R, Kulikowski CA, Maojo V, Martin-Sanchez F, Moorman PW, Moura LA, de Quirós FG, Schuemie MJ, Smith B, Talmon J.

Methods Inf Med. 2013;52(6):547-62.

PMID:
24310397
[PubMed - in process]
8.

Population-based analysis of non-steroidal anti-inflammatory drug use among children in four European countries in the SOS project: what size of data platforms and which study designs do we need to assess safety issues?

Valkhoff VE, Schade R, 't Jong GW, Romio S, Schuemie MJ, Arfe A, Garbe E, Herings R, Lucchi S, Picelli G, Schink T, Straatman H, Villa M, Kuipers EJ, Sturkenboom MC; Safety of Non-steroidal Anti-inflammatory Drugs (SOS) project.

BMC Pediatr. 2013 Nov 19;13:192. doi: 10.1186/1471-2431-13-192.

PMID:
24252465
[PubMed - indexed for MEDLINE]
Free Article
9.

Alternative outcome definitions and their effect on the performance of methods for observational outcome studies.

Reich CG, Ryan PB, Schuemie MJ.

Drug Saf. 2013 Oct;36 Suppl 1:S181-93. doi: 10.1007/s40264-013-0111-1.

PMID:
24166234
[PubMed - indexed for MEDLINE]
10.

Evaluating performance of risk identification methods through a large-scale simulation of observational data.

Ryan PB, Schuemie MJ.

Drug Saf. 2013 Oct;36 Suppl 1:S171-80. doi: 10.1007/s40264-013-0110-2.

PMID:
24166233
[PubMed - indexed for MEDLINE]
11.

Replication of the OMOP experiment in Europe: evaluating methods for risk identification in electronic health record databases.

Schuemie MJ, Gini R, Coloma PM, Straatman H, Herings RM, Pedersen L, Innocenti F, Mazzaglia G, Picelli G, van der Lei J, Sturkenboom MC.

Drug Saf. 2013 Oct;36 Suppl 1:S159-69. doi: 10.1007/s40264-013-0109-8.

PMID:
24166232
[PubMed - indexed for MEDLINE]
12.

A comparison of the empirical performance of methods for a risk identification system.

Ryan PB, Stang PE, Overhage JM, Suchard MA, Hartzema AG, DuMouchel W, Reich CG, Schuemie MJ, Madigan D.

Drug Saf. 2013 Oct;36 Suppl 1:S143-58. doi: 10.1007/s40264-013-0108-9.

PMID:
24166231
[PubMed - indexed for MEDLINE]
13.

Empirical performance of LGPS and LEOPARD: lessons for developing a risk identification and analysis system.

Schuemie MJ, Madigan D, Ryan PB.

Drug Saf. 2013 Oct;36 Suppl 1:S133-42. doi: 10.1007/s40264-013-0107-x.

PMID:
24166230
[PubMed - indexed for MEDLINE]
14.

Evaluation of disproportionality safety signaling applied to healthcare databases.

DuMouchel W, Ryan PB, Schuemie MJ, Madigan D.

Drug Saf. 2013 Oct;36 Suppl 1:S123-32. doi: 10.1007/s40264-013-0106-y.

PMID:
24166229
[PubMed - indexed for MEDLINE]
15.

Empirical performance of the calibrated self-controlled cohort analysis within temporal pattern discovery: lessons for developing a risk identification and analysis system.

Norén GN, Bergvall T, Ryan PB, Juhlin K, Schuemie MJ, Madigan D.

Drug Saf. 2013 Oct;36 Suppl 1:S107-21. doi: 10.1007/s40264-013-0095-x.

PMID:
24166228
[PubMed - indexed for MEDLINE]
16.

Empirical performance of a self-controlled cohort method: lessons for developing a risk identification and analysis system.

Ryan PB, Schuemie MJ, Madigan D.

Drug Saf. 2013 Oct;36 Suppl 1:S95-106. doi: 10.1007/s40264-013-0101-3.

PMID:
24166227
[PubMed - indexed for MEDLINE]
17.

Empirical performance of the self-controlled case series design: lessons for developing a risk identification and analysis system.

Suchard MA, Zorych I, Simpson SE, Schuemie MJ, Ryan PB, Madigan D.

Drug Saf. 2013 Oct;36 Suppl 1:S83-93. doi: 10.1007/s40264-013-0100-4.

PMID:
24166226
[PubMed - indexed for MEDLINE]
18.

Empirical performance of the case-control method: lessons for developing a risk identification and analysis system.

Madigan D, Schuemie MJ, Ryan PB.

Drug Saf. 2013 Oct;36 Suppl 1:S73-82. doi: 10.1007/s40264-013-0105-z.

PMID:
24166225
[PubMed - indexed for MEDLINE]
19.

Empirical performance of a new user cohort method: lessons for developing a risk identification and analysis system.

Ryan PB, Schuemie MJ, Gruber S, Zorych I, Madigan D.

Drug Saf. 2013 Oct;36 Suppl 1:S59-72. doi: 10.1007/s40264-013-0099-6.

PMID:
24166224
[PubMed - indexed for MEDLINE]
20.

Defining a reference set to support methodological research in drug safety.

Ryan PB, Schuemie MJ, Welebob E, Duke J, Valentine S, Hartzema AG.

Drug Saf. 2013 Oct;36 Suppl 1:S33-47. doi: 10.1007/s40264-013-0097-8. Review.

PMID:
24166222
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk